Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discontinuation of atorvastatin use in hospital is associated with increased risk of mortality in COVID‐19 patients
Laura Andrews, Laurel Goldin, Yan Shen, et al.
Journal of Hospital Medicine (2022) Vol. 17, Iss. 3, pp. 169-175
Open Access | Times Cited: 12

Showing 12 citing articles:

Protective effects of statins on COVID-19 risk, severity and fatal outcome: a nationwide Swedish cohort study
Ailiana Santosa, Stefan Franzén, Jonatan Nåtman, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 33
Atherosclerosis, Cardiovascular Disease, and COVID-19: A Narrative Review
Carles Vilaplana-Carnerero, Maria Giner‐Soriano, Ángela Domı́nguez, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1206-1206
Open Access | Times Cited: 14
Systematic Review and Meta-Analysis of Statin Use and Mortality, Intensive Care Unit Admission and Requirement for Mechanical Ventilation in COVID-19 Patients
Ut-Sam Lao, Chak-Fun Law, Daniel T. Baptista‐Hon, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 18, pp. 5454-5454
Open Access | Times Cited: 19
Discontinuation versus continuation of statins: A systematic review
Cayden Peixoto, Yasmeen Choudhri, Sara Francoeur, et al.
Journal of the American Geriatrics Society (2024) Vol. 72, Iss. 11, pp. 3567-3587
Open Access | Times Cited: 3
Atorvastatin Efficacy in the Management of Mild to Moderate Hospitalized COVID-19: A Pilot Randomized Triple-blind Placebo- controlled Clinical Trial
Sepideh Hejazi, Farzam Mircheraghi, Sepideh Elyasi, et al.
Recent Advances in Anti-Infective Drug Discovery (2022) Vol. 17, Iss. 3, pp. 212-222
Closed Access | Times Cited: 15
The impact of statin therapy on in‐hospital prognosis and endothelial function of patients at high‐to‐very high cardiovascular risk admitted for COVID‐19
Vanessa Bianconi, Massimo R. Mannarino, Elena Cosentini, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 3
Closed Access | Times Cited: 7
In Vitro Evidence of Statins’ Protective Role against COVID-19 Hallmarks
Donatella Fiore, Maria Proto, Silvia Franceschelli, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2123-2123
Open Access | Times Cited: 8
Treating COVID-19: Targeting the Host Response, Not the Virus
David S. Fedson
Life (2023) Vol. 13, Iss. 3, pp. 712-712
Open Access | Times Cited: 4
Can statins reduce mortality in critically ill COVID-19 patients? A retrospective cohort study
Heba A. Labib, Rania M. Ali, Ayman I. Tharwat
Egyptian Journal of Anaesthesia (2023) Vol. 39, Iss. 1, pp. 107-113
Open Access | Times Cited: 1
Late Onset Occurrence of Concomitant Myocardial Infarction and Ischemic Stroke in Hospitalized COVID-19 Patient: A Case Report
Antonio Ianniciello, Emilio Attena, Gerardo Carpinella, et al.
International Journal of General Medicine (2022) Vol. Volume 15, pp. 6621-6626
Open Access | Times Cited: 1
Statin Therapy to Improve Outcome of COVID-19 Patients: Useful or Not Useful?
Bruno Mégarbane
Journal of Personalized Medicine (2022) Vol. 12, Iss. 10, pp. 1627-1627
Open Access
Page 1

Scroll to top